Open‐Label Support for Duloxetine for the Treatment of Panic Disorder

Panic disorder with or without agoraphobia is a common, often chronic and refractory anxiety disorder. Although a number of pharmacotherapies are now indicated for panic disorder, many patients do not respond to available interventions. We hypothesized that duloxetine, a serotonin‐norepinephrine reu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Neurosci Ther
Main Authors: Simon, Naomi M., Kaufman, Rebecca E., Hoge, Elizabeth A., Worthington, John J., Herlands, Nannette N., Owens, Maryann E., Pollack, Mark H.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2009
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494018/
https://ncbi.nlm.nih.gov/pubmed/19228176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2008.00076.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados